Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck

PURPOSE: We conducted a Phase II, clinical trial to evaluate the efficacy and safety of a biweekly gemcitabine and paclitaxel (GEMTAX) regimen as second-line treatment in patients with recurrent or metastatic unresectable, squamous cell carcinoma of the head and neck (SCCHN). The primary endpoint wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukari, Ammar, Al-Hajeili, Marwan, Salem, Mohamed, Heilbrun, Lance, Smith, Daryn, Yoo, George, Jacobs, John R, Lin, Ho-Sheng, Kucuk, Omer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394570/
https://www.ncbi.nlm.nih.gov/pubmed/25878965
http://dx.doi.org/10.4103/2231-0770.154195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394570/
https://www.ncbi.nlm.nih.gov/pubmed/25878965
http://dx.doi.org/10.4103/2231-0770.154195

Ejemplares similares